Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Nektar Therapeutics (NKTR) had Current Ratio of 4.26 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$98.43M |
|
$-118.96M |
|
$30.69M |
|
$67.74M |
|
$203.62M |
|
$-105.20M |
|
$-14.00M |
|
$-119.20M |
|
$-119.20M |
|
$-118.96M |
|
$-118.96M |
|
$-118.96M |
|
$-118.96M |
|
$-105.20M |
|
$-100.81M |
|
13.72M |
|
13.72M |
|
$-8.70 |
|
$-8.70 |
|
| Balance Sheet Financials | |
$261.29M |
|
$3.41M |
|
$42.56M |
|
$303.85M |
|
$61.40M |
|
-- |
|
$181.71M |
|
$243.11M |
|
$60.74M |
|
$60.74M |
|
$60.74M |
|
12.39M |
|
| Cash Flow Statement Financials | |
$-175.71M |
|
$142.57M |
|
$42.12M |
|
$35.28M |
|
$44.25M |
|
$8.97M |
|
$21.61M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
4.26 |
-- |
|
-- |
|
-- |
|
-- |
|
68.82% |
|
-106.88% |
|
-106.88% |
|
-102.42% |
|
-121.11% |
|
-120.86% |
|
$-177.18M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
-- |
|
-- |
|
-- |
|
-195.86% |
|
-195.86% |
|
-39.15% |
|
-195.86% |
|
$4.90 |
|
$-12.92 |
|
$-12.81 |
|